125 related articles for article (PubMed ID: 36477484)
1. Dehydroepiandrosterone Sulfate and Mortality in Middle-Aged and Older Men and Women-A J-shaped Relationship.
Mukama T; Johnson T; Katzke V; Kaaks R
J Clin Endocrinol Metab; 2023 May; 108(6):e313-e325. PubMed ID: 36477484
[TBL] [Abstract][Full Text] [Related]
2. DHEAS levels and mortality in disabled older women: the Women's Health and Aging Study I.
Cappola AR; Xue QL; Walston JD; Leng SX; Ferrucci L; Guralnik J; Fried LP
J Gerontol A Biol Sci Med Sci; 2006 Sep; 61(9):957-62. PubMed ID: 16960027
[TBL] [Abstract][Full Text] [Related]
3. Trajectories of dehydroepiandrosterone sulfate predict mortality in older adults: the cardiovascular health study.
Cappola AR; O'Meara ES; Guo W; Bartz TM; Fried LP; Newman AB
J Gerontol A Biol Sci Med Sci; 2009 Dec; 64(12):1268-74. PubMed ID: 19713299
[TBL] [Abstract][Full Text] [Related]
4. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease.
Barrett-Connor E; Khaw KT; Yen SS
N Engl J Med; 1986 Dec; 315(24):1519-24. PubMed ID: 2946952
[TBL] [Abstract][Full Text] [Related]
5. Dehydroepiandrosterone, dehydroepiandrosterone sulphate and cardiovascular disease.
Khaw KT
J Endocrinol; 1996 Sep; 150 Suppl():S149-53. PubMed ID: 8943798
[TBL] [Abstract][Full Text] [Related]
6. Serum dehydroepiandrosterone sulfate and incident depression in the elderly: the Pro.V.A. study.
Veronese N; De Rui M; Bolzetta F; Zambon S; Corti MC; Baggio G; Toffanello ED; Crepaldi G; Perissinotto E; Manzato E; Sergi G
Am J Geriatr Psychiatry; 2015 Aug; 23(8):863-71. PubMed ID: 25537161
[TBL] [Abstract][Full Text] [Related]
7. Association of dehydroepiandrosterone sulfate, body composition, and physical fitness in independent community-dwelling older men and women.
Abbasi A; Duthie EH; Sheldahl L; Wilson C; Sasse E; Rudman I; Mattson DE
J Am Geriatr Soc; 1998 Mar; 46(3):263-73. PubMed ID: 9514370
[TBL] [Abstract][Full Text] [Related]
8. Serum dehydroepiandrosterone sulfate levels predict longevity in men: 27-year follow-up study in a community-based cohort (Tanushimaru study).
Enomoto M; Adachi H; Fukami A; Furuki K; Satoh A; Otsuka M; Kumagae S; Nanjo Y; Shigetoh Y; Imaizumi T
J Am Geriatr Soc; 2008 Jun; 56(6):994-8. PubMed ID: 18422949
[TBL] [Abstract][Full Text] [Related]
9. Dehydroepiandrosterone sulfate levels and risk of atrial fibrillation: the Rotterdam Study.
Krijthe BP; de Jong FH; Hofman A; Franco OH; Witteman JC; Stricker BH; Heeringa J
Eur J Prev Cardiol; 2014 Mar; 21(3):291-8. PubMed ID: 23152363
[TBL] [Abstract][Full Text] [Related]
10. Serum dehydroepiandrosterone and dehydroepiandrosterone sulfate and the subsequent risk of developing colon cancer.
Alberg AJ; Gordon GB; Hoffman SC; Comstock GW; Helzlsouer KJ
Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):517-21. PubMed ID: 10815698
[TBL] [Abstract][Full Text] [Related]
11. Serum dehydroepiandrosterone sulfate and adverse health outcomes in older men and women.
Forti P; Maltoni B; Olivelli V; Pirazzoli GL; Ravaglia G; Zoli M
Rejuvenation Res; 2012 Aug; 15(4):349-58. PubMed ID: 22524205
[TBL] [Abstract][Full Text] [Related]
12. Circulating dehydroepiandrosterone sulfate level and cardiovascular or all-cause mortality in the elderly population: a meta-analysis.
Li R; E L; Zha N
Ann Palliat Med; 2020 Sep; 9(5):3537-3545. PubMed ID: 32921089
[TBL] [Abstract][Full Text] [Related]
13. Low Serum Dehydroepiandrosterone and Dehydroepiandrosterone Sulfate Are Associated With Coronary Heart Disease in Men With Type 2 Diabetes Mellitus.
Zhang X; Xiao J; Liu T; He Q; Cui J; Tang S; Li X; Liu M
Front Endocrinol (Lausanne); 2022; 13():890029. PubMed ID: 35832423
[TBL] [Abstract][Full Text] [Related]
14. Relation of dehydroepiandrosterone and dehydroepiandrosterone sulfate with cardiovascular disease risk factors in women: longitudinal results from the Massachusetts Women's Health Study.
Johannes CB; Stellato RK; Feldman HA; Longcope C; McKinlay JB
J Clin Epidemiol; 1999 Feb; 52(2):95-103. PubMed ID: 10201649
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular disease is associated with greater incident dehydroepiandrosterone sulfate decline in the oldest old: the cardiovascular health study all stars study.
Sanders JL; Boudreau RM; Cappola AR; Arnold AM; Robbins J; Cushman M; Newman AB
J Am Geriatr Soc; 2010 Mar; 58(3):421-6. PubMed ID: 20163485
[TBL] [Abstract][Full Text] [Related]
16. The epidemiology of DHEAS and cardiovascular disease.
Barrett-Connor E; Goodman-Gruen D
Ann N Y Acad Sci; 1995 Dec; 774():259-70. PubMed ID: 8597464
[TBL] [Abstract][Full Text] [Related]
17. Dehydroepiandrosterone sulfate, diseases and mortality in a general aged population.
Tilvis RS; Kähönen M; Härkönen M
Aging (Milano); 1999 Feb; 11(1):30-4. PubMed ID: 10337439
[TBL] [Abstract][Full Text] [Related]
18. Dehydroepiandrosterone sulphate (DHEAS) in the oldest old, aged 85 and over.
Birkenhäger-Gillesse EG; Derksen J; Lagaay AM
Ann N Y Acad Sci; 1994 May; 719():543-52. PubMed ID: 8010622
[TBL] [Abstract][Full Text] [Related]
19. Higher serum dehydroepiandrosterone sulfate levels are protectively associated with depressive symptoms in men, but not in women: a community-based cohort study of older Japanese.
Michikawa T; Nishiwaki Y; Nakano M; Iwasawa S; Yamada M; Asakura K; Yoshioka N; Kuwahara E; Takebayashi T
Am J Geriatr Psychiatry; 2013 Nov; 21(11):1154-63. PubMed ID: 23567366
[TBL] [Abstract][Full Text] [Related]
20. Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: a French community-based study.
Berr C; Lafont S; Debuire B; Dartigues JF; Baulieu EE
Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13410-5. PubMed ID: 8917605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
